Radiology Business November 5, 2024
The Medicare program on Friday finalized plans to boost payment for certain diagnostic imaging agents delivered in the hospital outpatient setting.
First outlined in July, CMS is now moving forward with a proposal to issue separate payment for radiopharmaceuticals—a change long lobbied for by the imaging industry. For years, the agency has packaged payment for nuclear imaging agents with the procedure. However, this can create a barrier for those who require newer radiopharmaceuticals, advocates note.
Beginning Jan. 1, CMS will pay separately for diagnostic imaging agents with per-day costs above a threshold of $630. The Society of Nuclear Medicine & Molecular Imaging applauded the announcement Friday.
“This decision is a critical victory for patients who need advanced diagnostic...
Today's Sponsors
Today's Sponsor